Protein Phosphatase 2A B56α during Development in the Spontaneously Hypertensive Rat

Clinical and Experimental Hypertension

Volumn 26, Issue 3, 2004, Pages 243-254

  Yang, Zhiwei ^a   Yu, Peiying ^a   Asico, Laureano D ^a   Felder, Robin A ^b   Jose, Pedro A ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Development; Dopamine receptors; Hypertension; Phosphatase

Indexed keywords

DOPAMINE 1 RECEPTOR; PHOSPHOPROTEIN PHOSPHATASE 2A;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRUSH BORDER; CONTROLLED STUDY; DESENSITIZATION; DEVELOPMENT; ENZYME ACTIVITY; HYPERTENSION; IMMATURITY; IMMUNOPRECIPITATION; KIDNEY CELL; KIDNEY PROXIMAL TUBULE; NONHUMAN; PHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RAT STRAIN; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALS; BLOOD PRESSURE; CELL MEMBRANE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY; MICROVILLI; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN SUBUNITS; RATS; RATS, INBRED SHR; RATS, INBRED WKY;

EID: 1942533381     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.1081/CEH-120030233     Document Type: Article

References (36)

1. Wera S, Hemmings BA. Serine/threonine protein phosphatases. Biochem J 1995; 311(Pt 1):17-29.
2. Mumby MC, Walter G. Protein serine/threonine phosphatases: structure, regulation, and functions in cell growth. Physiol Rev 1993; 73(4):673-699.
3. Cohen PT. Novel protein serine/threonine phosphatases: variety is the spice of life. Trends Biochem Sci 1997; 22(7):245-251.
4. Ferguson SS. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 2001; 53(1):1-24.
5. Horvath KM, Radnai B, Bela TE, Fekete MI, Nagy GM. Inhibition of Protein phosphatase 2A (PP2A) mimics suckling-induced sensitization of mammotropes: involvement of a pertussis toxin (PTX) sensitive G-protein and the adenylate cyclase (AC). Mol Cell Endocrinol 1999; 149(1-2):1-7.
6. Millward TA, Zolnierowicz S, Hemmings BA. Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem Sci 1999; 24(5):186-191.
7. Shih M, Lin F, Scott JD, Wang HY, Malbon CC. Dynamic complexes of beta2-adrenergic receptors with protein kinases and phosphatases and the role of gravin. J Biol Chem 1999; 274(3):1588-1595.
8. Sontag E. Protein phosphatase 2A: the Trojan Horse of cellular signaling. Cell Signal 2001; 13(1):7-16.
9. Hemmings BA, Adams-Pearson C, Maurer F, Muller P, Goris J, Merlevede W, Hofsteenge J, Stone SR. Alpha- and beta-forms of the 65-kDa subunit of protein phosphatase 2A have a similar 39 amino acid repeating structure. Biochemistry 1990; 29(13):3166-3173.
10. Price NE, Mumby MC. Effects of regulatory subunits on the kinetics of protein phosphatase 2A. Biochemistry. 2000; 39(37):11312-11318.
11. McCright B, Rivers AM, Audlin S, Virshup DM. The B56 family of protein phosphatase 2A (PP2A) regulatory subunits encodes differentiation-induced phosphoproteins that target PP2A to both nucleus and cytoplasm. J Biol Chem 1996; 271(36):22081-22089.
12. Tehrani MA, Mumby MC, Kamibayashi C. Identification of a novel protein phosphatase 2A regulatory subunit highly expressed in muscle. J Biol Chem 1996; 271(9):5164-5171.
13. Zolnierowicz S, Csortos C, Bondor J, Verin A, Mumby MC, DePaoli-Roach. Diversity in the regulatory B-subunits of protein phosphatase 2A: identification of a novel isoform highly expressed in brain. Biochemistry 1994; 33(39):11858-11867.
14. Lifton RP. Molecular genetics of human blood pressure variation. Science 1996; 272(5262):676-680.
15. Jose PA, Eisner GM, Felder RA. Dopamine and the kidney: a role in hypertension? Curr Opin Nephrol Hypertens 2003; 12(2):189-194.
16. Amenta F, Ricci A, Rossodivita I, Avola R, Tayebati SK. The dopaminergic system in hypertension. Clin Exp Hypertens 2001; 23(1-2):15-24.
17. Hussain T, Lokhandwala MF. Renal dopamine receptor function in hypertension. Hypertension 1998; 32(2):187-197.
18. +-ATPase activity is lacking in Dahl salt-sensitive rats. Hypertension 1993; 21(6 Pt 1):767-771.
19. Debska-Slizien A, Ho P, Drangova R, Baines AD. Endogenous dopamine regulates phosphate reabsorption but not NaK-ATPase in spontaneously hypertensive rat kidneys. J Am Soc Nephrol 1994; 5(4):1125-1132.
20. Kinoshita S, Sidhu A, Felder RA. Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat. J Clin Invest 1989; 84(6):1849-1856.
21. Felder RA, Sanada H, Xu J, Yu PY, Wang Z, Watanabe H, Asico LD, Wang W, Zheng S, Yamaguchi I, Williams SM, Gainer J, Brown NJ, Hazen-Martin D, Wong LJ, Robillard JE, Carey RM, Eisner GM, Jose PA. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci U S A 2002; 99(6):3872-3877.
22. +-ATPase endocytosis. J Biol Chem 2002; 277(46):44108-44114.
23. Yu PY, Asico LD, Eisner GM, Hopfer U, Felder RA, Jose PA. Renal protein phosphatase 2A activity and spontaneous hypertension in rats. Hypertension 2000; 36(6):1053-1058.
24. Albrecht FE, Drago J, Felder RA, Printz MP, Eisner GM, Robillard JE, Sibley DR, Westphal HJ, Jose PA. Role of the D1A dopamine receptor in the pathogenesis of genetic hypertension. J Clin Invest 1996; 97(10):2283-2288.
25. 13-protein subunit linkage of D5 dopamine receptors in the nephron. Hypertension 2003; 41(3):604-610.
26. Everett AD, Xue C, Stoops T. Developmental expression of protein phosphatase 2A in the kidney. J Am Soc Nephrol 1999; 10(8):1737-1745.
27. Hall JE, Guyton AC, Brands MW. Pressure-volume regulation in hypertension. Kidney Int Suppl 1996; 55:S35-S41.
28. Jose PA, Raymond JR, Bates MD, Aperia A, Felder RA, Carey RM. The renal dopamine receptors. J Am Soc Nephrol 1992; 2(8):1265-1278.
29. Wang ZQ, Felder RA, Carey RM. Selective inhibition of the renal dopamine subtype D1A receptor induces antinatriuresis in conscious rats. Hypertension 1999; 33(1 Pt 2):504-510.
30. Felder RA, Seikaly MG, Cody P, Eisner GM, Jose PA. Attenuated renal response to dopaminergic drugs in spontaneously hypertensive rats. Hypertension 1990; 15(6 Pt 1):560-569.
31. Chen CJ, Lokhandwala MF. An impairment of renal tubular DA-1 receptor function as the causative factor for diminished natriuresis to volume expansion in spontaneously hypertensive rats. Clin Exp Hypertens A 1992; 14(4):615-628.
32. +-ATPase activity in Dahl salt-resistant but not in Dahl salt-sensitive rats: evidence of defective dopamine regulation. Acta Physiol Scand 1992; 144(3):263-267.
33. Felder RA, Kinoshita S, Ohbu K, Mouradian MM, Sibley DR, Monsma FJ Jr, Minowa T, Minowa MT, Canessa LM, Jose PA. Organ specificity of the dopamine1 receptor/adenylyl cyclase coupling defect in spontaneously hypertensive rats. Am J Physiol 1993; 264(4 Pt 2):R726-R732.
34. Yamaguchi I, Jose PA, Mouradian MM, Canessa LM, Monsma FJ Jr, Sibley DR, Takeyasu K, Felder RA. Expression of dopamine D1A receptor gene in proximal tubule of rat kidneys. Am J Physiol 1993; 264(2 Pt 2):F280-F285.
35. Ozono R, O'Connell DP, Wang ZQ, Moore AF, Sanada H, Felder RA, Carey RM. Localization of the dopamine D1 receptor protein in the human heart and kidney. Hypertension 1997; 30(3 Pt 2):725-729.
36. O'Connell DP, Aherne AM, Lane E, Felder RA, Carey RM. Detection of dopamine receptor D1A subtype-specific mRNA in rat kidney by in situ amplification. Am J Physiol 1998; 274(1 Pt 2):F232-F241.